Previous Close | 65.55 |
Open | 0.00 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's Range | 57.39 - 57.39 |
52 Week Range | 57.39 - 65.55 |
Volume | |
Avg. Volume | 0 |
Market Cap | 71.564B |
Beta (5Y Monthly) | 0.20 |
PE Ratio (TTM) | 17.55 |
EPS (TTM) | 3.27 |
Earnings Date | Apr 25, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Jun 14, 2024 |
1y Target Est | N/A |
NORTHAMPTON, MA / ACCESSWIRE / May 3, 2024 / Gilead Sciences Forbes has listed Gilead as one of America's Best Employers for Diversity. We believe that by championing inclusion and diversity, we not only enrich our workplace but also drive groundbreaking ...
FOSTER CITY, Calif., April 30, 2024--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:
Gilead Sciences ( NASDAQ:GILD ) First Quarter 2024 Results Key Financial Results Revenue: US$6.69b (up 5.3% from 1Q...